<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02814162</url>
  </required_header>
  <id_info>
    <org_study_id>TDSJWKSAH</org_study_id>
    <nct_id>NCT02814162</nct_id>
  </id_info>
  <brief_title>Predictive Values of Serum Adiponectin Levels in Aneurysmal Subarachnoid Hemorrhage.</brief_title>
  <official_title>Predictive Values of Serum Adiponectin Levels in Aneurysmal Subarachnoid Hemorrhage.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the predictive value of serum adiponectin levels in
      aneurysmal subarachnoid hemorrhage patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adiponectin (APN) is an abundant protein hormone derived from adipose tissue. It has been
      suggested to exert anti-inflammatory, antiatherogenic, and vascular protective. Subarachnoid
      hemorrhage (SAH) comprises about 5% of all strokes with high mortality and permanent
      disability rates. Although many patients survive from the initial hemorrhage or rebleeding,
      they suffered from long-term delayed neurological deficits (DNDs), including stroke, delayed
      cerebral ischemia, cognitive and neuropsychological abnormalities that seriously impact
      overall function and quality of life. Ruptured cerebral aneurysms are the most common cause
      of SAH. There is growing evidence supporting APN act as a predictive factor for SAH. The
      observational study will focus on the predictive value of serum adiponectin levels in
      aneurysmal subarachnoid hemorrhage (aSAH).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of cerebral vasospasm and delayed cerebral ischemia</measure>
    <time_frame>30 days post SAH</time_frame>
    <description>Proved by clinical and radiologic evidence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>30 days post SAH</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National institutes of health stroke scale (NIHSS) score</measure>
    <time_frame>On discharge or 14 days (whichever occurs first) and 30 days post SAH</time_frame>
    <description>Assessing by senior neurosurgeons</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin scale (mRS)</measure>
    <time_frame>30 days and 90days post SAH</time_frame>
    <description>By phone call following-up</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Subarachnoid Hemorrhage, Aneurysmal</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with aneurysmal subarachnoid hemorrhage who are hospitalized within 24 hours from
        onset.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18yrs and age&lt;90yrs

          -  It shows subarachnoid hemorrhage (SAH) based on computed tomography (CT) scan on
             admission

          -  Aneurysmal subarachnoid hemorrhage confirmed by computed tomography angiography (CTA),
             magnetic resonance angiography (MRA) or digital subtraction angiography (DSA)

          -  SAH grade is assessed by Hunt &amp; Hess classification

          -  Informed consented

        Exclusion Criteria:

          -  Traumatic subarachnoid hemorrhage

          -  Patients with cerebral herniation or highly possible to occur within 2 days from SAH

          -  Length of hospital stay is expected to be less than 5 days

          -  Duration from onset to admission is more than 48 hours

          -  Disturbance of communication or poor compliance to blood collection, imaging
             examination and follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yan Qu, M.D Ph.D</last_name>
    <phone>86-18629074363</phone>
    <email>yanqu0123@icloud.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Min Li, M.D Ph.D</last_name>
    <phone>86-15319053136</phone>
    <email>neursylm@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tandu Hospital, Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Qu, M.D Ph.D</last_name>
      <phone>86-18629074363</phone>
      <email>yanqu0123@icloud.com</email>
    </contact>
    <contact_backup>
      <last_name>Min Li, M.D Ph.D</last_name>
      <phone>86-15319053136</phone>
      <email>neursylm@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Thundyil J, Tang SC, Okun E, Shah K, Karamyan VT, Li YI, Woodruff TM, Taylor SM, Jo DG, Mattson MP, Arumugam TV. Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. Exp Transl Stroke Med. 2010 Aug 11;2(1):15. doi: 10.1186/2040-7378-2-15.</citation>
    <PMID>20701790</PMID>
  </reference>
  <reference>
    <citation>Osuka K, Watanabe Y, Yasuda M, Takayasu M. Adiponectin activates endothelial nitric oxide synthase through AMPK signaling after subarachnoid hemorrhage. Neurosci Lett. 2012 Apr 11;514(1):2-5. doi: 10.1016/j.neulet.2011.12.041. Epub 2012 Jan 3.</citation>
    <PMID>22230897</PMID>
  </reference>
  <reference>
    <citation>Psilopanagioti A, Papadaki H, Kranioti EF, Alexandrides TK, Varakis JN. Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology. 2009;89(1):38-47. doi: 10.1159/000151396. Epub 2008 Aug 13.</citation>
    <PMID>18698133</PMID>
  </reference>
  <reference>
    <citation>Kos K, Harte AL, da Silva NF, Tonchev A, Chaldakov G, James S, Snead DR, Hoggart B, O'Hare JP, McTernan PG, Kumar S. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab. 2007 Mar;92(3):1129-36. Epub 2007 Jan 9.</citation>
    <PMID>17213280</PMID>
  </reference>
  <reference>
    <citation>Kusminski CM, McTernan PG, Schraw T, Kos K, O'Hare JP, Ahima R, Kumar S, Scherer PE. Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia. 2007 Mar;50(3):634-42. Epub 2007 Jan 23.</citation>
    <PMID>17242917</PMID>
  </reference>
  <reference>
    <citation>Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke. 2005 Sep;36(9):1915-9. Epub 2005 Aug 18.</citation>
    <PMID>16109902</PMID>
  </reference>
  <reference>
    <citation>Takeuchi S, Wada K, Otani N, Osada H, Nagatani K, Mori K. Temporal profile of plasma adiponectin level and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Clin Neurosci. 2014 Jun;21(6):1007-10. doi: 10.1016/j.jocn.2013.10.020. Epub 2013 Dec 22.</citation>
    <PMID>24594449</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>March 29, 2017</last_update_submitted>
  <last_update_submitted_qc>March 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Subarachnoid Hemorrhage, Aneurysmal</keyword>
  <keyword>Predictive</keyword>
  <keyword>Adiponectin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

